PRINTER'S NO. 1529
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
337
Session of
2015
INTRODUCED BY BARRAR, V. BROWN, COHEN, CORBIN, CUTLER, DeLUCA,
A. HARRIS, MARSICO, McGINNIS, MILLARD, MURT, PICKETT,
RAVENSTAHL, READSHAW, ROZZI, SAYLOR, THOMAS AND WATSON,
MAY 12, 2015
REFERRED TO COMMITTEE ON HEALTH, MAY 12, 2015
A RESOLUTION
Strongly urging the members of Congress of the United States
from Pennsylvania to demand the United States Food and Drug
Administration immediately approve the drug GM604 to treat
Amyotrophic Lateral Sclerosis.
WHEREAS, Amyotrophic Lateral Sclerosis (ALS) is better known
as Lou Gehrig's Disease; and
WHEREAS, ALS is a fatal neurodegenerative disease
characterized by degeneration of cell bodies of the upper and
lower motor neurons in the gray matter of the anterior horn of
the spinal cord; and
WHEREAS, The initial symptom of ALS is weakness of the
skeletal muscles, especially those of the extremities; and
WHEREAS, As ALS progresses, the patient experiences
difficulty in swallowing, talking and breathing; and
WHEREAS, ALS eventually causes muscles to atrophy and the
patient becomes a functional quadriplegic; and
WHEREAS, Patients with ALS typically remain alert and aware
of their loss of motor functions and the inevitable outcome of
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18